Delivery Order SPE2DE24D0013-SPE2D626F24CE
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $4,147.56 under contract number XPRSMVP-10 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order represents a child contract with no set-aside designation and is classified as a Defense-oriented procurement. The contract is being performed at Cepheid's Sunnyvale, California facility, where the company...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $2,765.04 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with ultimate completion by January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, requires no set-aside designation and is being performed at Cepheid's Sunnyvale headquarters. The contract falls under the company's established relationship with the Defense...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency's Medical Supply Chain on January 20, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a child contract under a larger indefinite delivery vehicle and calls for completion by January 27, 2026. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,595.60 by the Defense Logistics Agency Medical Supply Chain under contract number GXGBSLBXC-10. This firm fixed-price delivery order, issued on January 20, 2026, is expected to be completed by January 27, 2026, and represents a child contract under a larger indefinite delivery vehicle. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal...
- Cepheid Inc., headquartered in Sunnyvale, California, received a delivery order valued at $4,791.90 from the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order, issued under contract GXCT/NG-10, represents a child contract with no set-aside designation. The order falls under Cepheid's established relationship with DLA as a primary federal supplier of molecular diagnostic systems and...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a firm fixed-price delivery order valued at $1,104.00 by the Defense Logistics Agency Medical Supply Chain, with an award date of November 25, 2025, and ultimate completion date of December 3, 2025. The delivery order, designated XPRSTREPA-10, represents procurement under a broader contracting vehicle and carries no set-aside designation. Cepheid is a specialized manufacturer of advanced molecular diagnostic systems and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $32,719.64 on December 4, 2025, under a Defense Logistics Agency Medical Supply Chain contract. The delivery order, designated XPRSMVP-10 with contract number 4570171770, carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of December 11, 2025. Based on Cepheid's established federal contracting history, this...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F24CEDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on January 23, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, is expected to be completed by January 30, 2026, and represents a child contract under Cepheid's existing Indefinite Delivery Contracts with federal healthcare agencies. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. As a key supplier to multiple federal healthcare entities including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency, Cepheid will fulfill this order from its Sunnyvale, California location. This delivery order is issued under Cepheid's broader federal contracting relationship with the Defense Logistics Agency Medical Supply Chain, which has awarded the company numerous contracts for diagnostic testing supplies, test kits, and reagents. The contract aligns with Cepheid's core competency in supplying molecular diagnostic solutions, particularly the GeneXpert diagnostic platform and associated testing capabilities for infectious diseases. The modest contract value and abbreviated performance timeline suggest this represents a routine replenishment order for diagnostic supplies or reagents supporting military medical operations and federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 1/22/26 |